EP3611169
Ný gadólíníumklósambönd til notkunar við segulómmyndatöku
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.5.2016EP published:
21.7.2021EP application number:
19194723.3
EP translation filed:
21.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
29.5.2036Expiry date:
29.5.2025
Title:
NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
Timeline
Today
30.5.2016EP application
21.7.2021EP Publication
21.9.2021Translation submitted
15.10.2021Registration published
29.5.2025Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353 Berlin, DE
Inventor
Name:
Berger, MarkusAddress:
12167 Berlin, DE
Name:
Lohrke, JessicaAddress:
12351 Berlin, DE
Name:
Hilger, Christoph-StephanAddress:
13503 Berlin, DE
Name:
Jost, GregorAddress:
10318 Berlin, DE
Name:
Fenzel, ThomasAddress:
12247 Berlin, DE
Name:
Suelzle, DetlevAddress:
13465 Berlin, DE
Name:
Platzek, JohannesAddress:
12621 Berlin, DE
Name:
Panknin, OlafAddress:
13187 Berlin, DE
Name:
Pietsch, HubertusAddress:
14532 Kleinmachnow, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15170658Date:
4.6.2015Country:
EP
Classification
Categories:
C07D 257/02, C07C 229/16, A61K 49/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 28.4.2022
Expires: 29.5.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.4.2023
Expires: 29.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.4.2024
Expires: 29.5.2025
Payer: Árnason Faktor ehf.